Active
Psilocybin / psychedelic regulatory landscape
Bob Hoban, Hoban Law Group · Last updated May 2026
On-record soundbite (1–2 sentences)
“The psychedelic regulatory arc is following the cannabis playbook about a decade behind — ballot initiatives, medical carve-outs, and regulatory frameworks that are more restrictive than the science requires. Operators entering this space should expect a long regulatory runway and plan accordingly.”
— Robert Hoban, Hoban Law Group
Extended quote (3–4 sentences)
“The psychedelic regulatory arc is following the cannabis playbook about a decade behind — ballot initiatives, medical carve-outs, and regulatory frameworks that are more restrictive than the science requires. Operators entering this space should expect a long regulatory runway and plan accordingly. Oregon's psilocybin service model and Colorado's natural medicine framework are the two live experiments. Neither has resolved the fundamental tensions around scope of practice, facilitator liability, and insurance coverage. The legal infrastructure for this industry is being built in real time, and the decisions made in the next two years will constrain the market for a generation.”
— Robert Hoban, Hoban Law Group
Attribution
Robert Hoban, Founder and Managing Partner, Hoban Law Group. Quotes may be used in editorial coverage with this attribution line. For background briefings or custom quotes on adjacent topics, contact the press team.